• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡相关的mir-21和mir-144在肝细胞癌患者血清中显著升高。

Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma.

作者信息

Pu Chunwen, Huang Hui, Wang Zhidong, Zou Wei, Lv Yuecai, Zhou Zhiyuan, Zhang Qiqi, Qiao Liang, Wu Fei, Shao Shujuan

机构信息

Department of Biobank, The Affiliated Sixth People's Hospital of Dalian Medical University, Dalian, China.

The Affiliated Zhongshan Hospital of Dalian University, Dalian, China.

出版信息

Front Physiol. 2018 Jul 17;9:930. doi: 10.3389/fphys.2018.00930. eCollection 2018.

DOI:10.3389/fphys.2018.00930
PMID:30065664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6056643/
Abstract

The aim of this study was to observe the possible change of microRNAs (miRNAs) in serum extracellular vesicles (EVs) from hepatocellular carcinoma (HCC) patients. The serum EVs were purified from 17 healthy donors, 16 chronic hepatitis B (CHB) patients and 24 HCC patients. The sequenced microRNAs in the purified EVs were analyzed to obtain highly differentially expressed genes (DEGs). Finally, the expression pattern of DEGs was validated using qRT-PCR. We found that the expression of hsa-miR-21-5p and hsa-miR-144-3p were significantly higher in EVs and liver cancer tissues compared with serum and the distal liver tissues in HCC patients. The ratio of hsa-miR-144-3p/hsa-miR-21-5p was significantly decreased in the patients with CHB but significantly increased in patients with HCC developed from CHB ( < 0.05). Hsa-144-3p/hsa-miR-21-5p exhibited greater performance than alpha-fetoprotein (AUC 0.780, 95% CI 0.601-0.960, versus AUC 0.626, 95% CI 0.410-0.843) in ROC curve analysis. Extracellular vesicle-associated hsa-miR-21-5p and hsa-miR-144-3p are markedly elevated in serum of patients with HCC. The potential role of these microRNAs in the pathogenesis of HCC is worth of further study.

摘要

本研究旨在观察肝细胞癌(HCC)患者血清细胞外囊泡(EVs)中微小RNA(miRNAs)的可能变化。从17名健康供体、16名慢性乙型肝炎(CHB)患者和24名HCC患者中纯化血清EVs。对纯化后的EVs中测序的微小RNA进行分析,以获得高度差异表达基因(DEGs)。最后,使用qRT-PCR验证DEGs的表达模式。我们发现,与HCC患者的血清和肝远端组织相比,hsa-miR-21-5p和hsa-miR-144-3p在EVs和肝癌组织中的表达显著更高。CHB患者中hsa-miR-144-3p/hsa-miR-21-5p的比值显著降低,但CHB发展而来的HCC患者中该比值显著升高(<0.05)。在ROC曲线分析中,hsa-144-3p/hsa-miR-21-5p表现出比甲胎蛋白更好的性能(AUC 0.780,95%CI 0.601-0.960,对比AUC 0.626,95%CI 0.410-0.843)。细胞外囊泡相关的hsa-miR-21-5p和hsa-miR-144-3p在HCC患者血清中明显升高。这些微小RNA在HCC发病机制中的潜在作用值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/ec553af9a220/fphys-09-00930-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/2dd0f3bbea76/fphys-09-00930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/83337b748f38/fphys-09-00930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/a282283c69ad/fphys-09-00930-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/ec553af9a220/fphys-09-00930-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/2dd0f3bbea76/fphys-09-00930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/83337b748f38/fphys-09-00930-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/a282283c69ad/fphys-09-00930-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/251e/6056643/ec553af9a220/fphys-09-00930-g004.jpg

相似文献

1
Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma.细胞外囊泡相关的mir-21和mir-144在肝细胞癌患者血清中显著升高。
Front Physiol. 2018 Jul 17;9:930. doi: 10.3389/fphys.2018.00930. eCollection 2018.
2
Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.帕金森病患者血浆细胞外囊泡中 miRNA 的差异表达及意义。
Int J Neurosci. 2022 Jul;132(7):673-688. doi: 10.1080/00207454.2020.1835899. Epub 2020 Oct 26.
3
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
4
Characterization and microRNA Expression Analysis of Serum-Derived Extracellular Vesicles in Severe Liver Injury from Chronic HBV Infection.慢性乙型肝炎病毒感染所致严重肝损伤中血清来源细胞外囊泡的表征及微小RNA表达分析
Life (Basel). 2023 Jan 28;13(2):347. doi: 10.3390/life13020347.
5
Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.阿尔茨海默病血浆来源细胞外囊泡中致病蛋白和微小RNA的概况:一项初步研究
Neuroscience. 2020 Apr 15;432:240-246. doi: 10.1016/j.neuroscience.2020.02.044. Epub 2020 Mar 3.
6
Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.基于 miRNA 表达谱鉴定肝癌的预后标志物。
Life Sci. 2019 Sep 1;232:116596. doi: 10.1016/j.lfs.2019.116596. Epub 2019 Jun 22.
7
Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.循环 miRNA-223-3p 在乙型肝炎病毒相关肝细胞癌中的诊断和预后作用。
PLoS One. 2020 Apr 24;15(4):e0232211. doi: 10.1371/journal.pone.0232211. eCollection 2020.
8
Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.与乙型肝炎病毒相关的肝硬化发展为肝细胞癌过程中血清微小RNA的差异表达
Oncol Rep. 2015 Jun;33(6):2863-70. doi: 10.3892/or.2015.3924. Epub 2015 Apr 24.
9
Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.血清微小RNA检测 panel 作为丙氨酸氨基转移酶持续正常的慢性乙型肝炎潜在生物标志物
Clin Chim Acta. 2015 Dec 7;451(Pt B):232-9. doi: 10.1016/j.cca.2015.10.002. Epub 2015 Oct 17.
10
MicroRNA analysis of medium/large placenta extracellular vesicles in normal and preeclampsia pregnancies.正常妊娠和子痫前期妊娠中/大型胎盘细胞外囊泡的微小RNA分析
Front Cardiovasc Med. 2024 Apr 2;11:1371168. doi: 10.3389/fcvm.2024.1371168. eCollection 2024.

引用本文的文献

1
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
2
miRNAs-Set of Plasmatic Extracellular Vesicles as Novel Biomarkers for Hepatocellular Carcinoma Diagnosis Across Tumor Stage and Etiologies.作为跨肿瘤分期和病因的肝细胞癌诊断新型生物标志物的血浆细胞外囊泡中的miRNA组
Int J Mol Sci. 2025 Mar 12;26(6):2563. doi: 10.3390/ijms26062563.
3
Novel biomarkers for monitoring and management of hepatocellular carcinoma.

本文引用的文献

1
Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.静脉注射miR-144可抑制二乙基亚硝胺诱导的小鼠肝细胞癌的肿瘤生长。
Tumour Biol. 2017 Oct;39(10):1010428317737729. doi: 10.1177/1010428317737729.
2
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.深入了解miR-144-3p在肝细胞癌中的临床病理意义。
Onco Targets Ther. 2017 Jul 11;10:3405-3419. doi: 10.2147/OTT.S138143. eCollection 2017.
3
MiR-21: A key player in glioblastoma pathogenesis.
用于监测和管理肝细胞癌的新型生物标志物。
Cancer Cell Int. 2024 Dec 24;24(1):428. doi: 10.1186/s12935-024-03600-1.
4
Distinct immunomodulation elicited by young versus aged extracellular vesicles in bone marrow-derived macrophages.年轻与衰老的细胞外囊泡对骨髓来源巨噬细胞产生的不同免疫调节作用。
Immun Ageing. 2024 Oct 21;21(1):72. doi: 10.1186/s12979-024-00472-x.
5
Risk factors for varus knee osteoarthritis and their relationship with disease severity based on Kellgren-Lawrence classification.基于凯尔格伦-劳伦斯分类法的膝内翻骨关节炎危险因素及其与疾病严重程度的关系。
Am J Transl Res. 2024 Sep 15;16(9):4912-4919. doi: 10.62347/YMJV4880. eCollection 2024.
6
High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis.细胞外囊泡的高通量表面表位免疫亲和分离及下游分析
Biol Methods Protoc. 2024 May 17;9(1):bpae032. doi: 10.1093/biomethods/bpae032. eCollection 2024.
7
Gemcitabine and synthesized silver nanoparticles impact on chemically induced hepatocellular carcinoma in male rats.吉西他滨与合成银纳米颗粒对雄性大鼠化学诱导肝细胞癌的影响。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241263352. doi: 10.1177/03946320241263352.
8
Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases.揭示细胞外囊泡作为胃肠道疾病生物标志物和治疗纳米工具的潜力。
Pharmaceutics. 2024 Apr 21;16(4):567. doi: 10.3390/pharmaceutics16040567.
9
APOB is a potential prognostic biomarker in hepatocellular carcinoma.载脂蛋白B是肝细胞癌中一种潜在的预后生物标志物。
Discov Oncol. 2024 Feb 3;15(1):28. doi: 10.1007/s12672-024-00877-6.
10
Liquid biopsy for early detection of hepatocellular carcinoma.用于肝细胞癌早期检测的液体活检
Front Med (Lausanne). 2023 Sep 22;10:1218705. doi: 10.3389/fmed.2023.1218705. eCollection 2023.
miR-21:胶质母细胞瘤发病机制中的关键分子。
J Cell Biochem. 2018 Feb;119(2):1285-1290. doi: 10.1002/jcb.26300. Epub 2017 Aug 28.
4
MicroRNA-144-3p inhibits autophagy activation and enhances Bacillus Calmette-Guérin infection by targeting ATG4a in RAW264.7 macrophage cells.微小RNA-144-3p通过靶向RAW264.7巨噬细胞中的自噬相关基因4a(ATG4a)抑制自噬激活并增强卡介苗感染。
PLoS One. 2017 Jun 21;12(6):e0179772. doi: 10.1371/journal.pone.0179772. eCollection 2017.
5
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.循环中的miR-21作为肝细胞癌的血清生物标志物,与远处转移相关。
Oncotarget. 2017 Jul 4;8(27):44050-44058. doi: 10.18632/oncotarget.17211.
6
Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.循环外泌体微小RNA-21作为结直肠癌各肿瘤分期的生物标志物
Oncology. 2017;92(6):360-370. doi: 10.1159/000463387. Epub 2017 Apr 5.
7
MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.微小RNA-144通过靶向锌指蛋白X(ZFX)抑制肝癌细胞的增殖、侵袭和迁移。
J Biosci. 2017 Mar;42(1):103-111. doi: 10.1007/s12038-016-9662-5.
8
MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.MIR144* 通过靶向自噬蛋白DRAM2抑制人单核细胞和巨噬细胞对结核分枝杆菌的抗菌反应。
Autophagy. 2017 Feb;13(2):423-441. doi: 10.1080/15548627.2016.1241922. Epub 2016 Oct 20.
9
Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer.miR-144过表达在人类食管癌中的潜在诊断意义。
Indian J Med Res. 2016 May;143(Supplement):S91-S103. doi: 10.4103/0971-5916.191796.
10
MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4.微小RNA-144通过靶向SMAD4抑制肝细胞癌的细胞增殖、迁移和侵袭。
Onco Targets Ther. 2016 Jul 29;9:4705-14. doi: 10.2147/OTT.S88233. eCollection 2016.